Endologix Reports First Quarter 2017 Financial Results

Go back to Endologix Reports First Quarter 2017 Financial Results

Endologix (ELGX) Misses Q1 EPS by 5c

May 4, 2017 4:40 PM EDT

Endologix (NASDAQ: ELGX) reported Q1 EPS of ($0.26), $0.05 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $42.6 million versus the consensus estimate of $41.11 million.

Financial Guidance

Endologix reaffirms its previously issued revenue guidance and continues to anticipate 2017 revenue to be in... More